N'-[(1E)-[2-(Diethylamino)-1,3-thiazol-5-yl]methylidene]pyridine-4-carbohydrazide

Catalog No. :
ACJKGF077
CAS No. :
477855-20-2
Molecular Formula :
C14H17N5OS
Molecular Weight :
303.39

IUPAC Name:(E)-N'-((2-(diethylamino)thiazol-5-yl)methylene)isonicotinohydrazide

N'-[(1E)-[2-(Diethylamino)-1,3-thiazol-5-yl]methylidene]pyridine-4-carbohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$567.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN'-[(1E)-[2-(Diethylamino)-1,3-thiazol-5-yl]methylidene]pyridine-4-carbohydrazide
IUPAC Name(E)-N'-((2-(diethylamino)thiazol-5-yl)methylene)isonicotinohydrazide
MDL No.MFCD01814550
Molecular FormulaC14H17N5OS
Molecular Weight303.39
SMILESO=C(C1=CC=NC=C1)N/N=C/C2=CN=C(N(CC)CC)S2
InChI KeyDWROXXZCHRRDAA-LICLKQGHSA-N
SynonymN'-((E)-[2-(DIETHYLAMINO)-1,3-THIAZOL-5-YL]METHYLIDENE)ISONICOTINOHYDRAZIDE;4-Pyridinecarboxylic acid, 2-[[2-(diethylamino)-5-thiazolyl]methylene]hydrazide
CAS No.477855-20-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJKGF077 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEROX892 route compound structure diagram
    ACEROX89254-85-3 In Stock
  4. Then
  5. ACJKGF077 route product structure diagram
    ACJKGF077477855-20-2
Inquiry

2. ACJKGF077 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJKGF077 route product structure diagram
    ACJKGF077477855-20-2
Inquiry

Comments (0)